Summit Trail Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.99M | Buy |
43,038
+7,018
| +19% | +$1.3M | 0.14% | 86 |
|
|
2025
Q1 | $7.55M | Buy |
36,020
+6,544
| +22% | +$1.37M | 0.25% | 42 |
|
|
2024
Q4 | $5.24M | Buy |
29,476
+5,053
| +21% | +$898K | 0.19% | 42 |
|
|
2024
Q3 | $4.82M | Buy |
24,423
+3,865
| +19% | +$763K | 0.12% | 81 |
|
|
2024
Q2 | $3.53M | Buy |
20,558
+2,924
| +17% | +$502K | 0.09% | 94 |
|
|
2024
Q1 | $3.21M | Sell |
17,634
-2,608
| -13% | -$475K | 0.09% | 90 |
|
|
2023
Q4 | $3.14M | Buy |
20,242
+920
| +5% | +$143K | 0.1% | 72 |
|
|
2023
Q3 | $2.88M | Buy |
19,322
+1,801
| +10% | +$268K | 0.11% | 78 |
|
|
2023
Q2 | $2.36M | Buy |
17,521
+10,856
| +163% | +$1.46M | 0.09% | 93 |
|
|
2023
Q1 | $1.06M | Buy |
6,665
+400
| +6% | +$63.7K | 0.04% | 122 |
|
|
2022
Q4 | $1.01M | Buy |
6,265
+402
| +7% | +$65K | 0.05% | 116 |
|
|
2022
Q3 | $787K | Buy |
5,863
+2,719
| +86% | +$365K | 0.04% | 125 |
|
|
2022
Q2 | $482K | Sell |
3,144
-17
| -0.5% | -$2.61K | 0.03% | 194 |
|
|
2022
Q1 | $512K | Buy |
3,161
+715
| +29% | +$116K | 0.04% | 168 |
|
|
2021
Q4 | $331K | Buy |
2,446
+43
| +2% | +$5.82K | 0.02% | 214 |
|
|
2021
Q3 | $259K | Buy |
+2,403
| New | +$259K | 0.02% | 220 |
|
|
2020
Q4 | – | Sell |
-3,584
| Closed | -$354K | – | 187 |
|
|
2020
Q3 | $354K | Buy |
+3,584
| New | +$354K | 0.07% | 132 |
|
|
2019
Q1 | – | Sell |
-3,497
| Closed | -$322K | – | 84 |
|
|
2018
Q4 | $322K | Sell |
3,497
-3,724
| -52% | -$343K | 0.11% | 76 |
|
|
2018
Q3 | $683K | Buy |
7,221
+3,497
| +94% | +$331K | 0.15% | 81 |
|
|
2018
Q2 | $345K | Sell |
3,724
-8,084
| -68% | -$749K | 0.12% | 97 |
|
|
2018
Q1 | $997K | Sell |
11,808
-1,081
| -8% | -$91.3K | 0.17% | 135 |
|
|
2017
Q4 | $1.33M | Buy |
+12,889
| New | +$1.33M | 0.17% | 121 |
|